Cargando…
A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders
BACKGROUND: L-carnitine was proposed as a potential treatment for patients diagnosed with an autism spectrum disorder to improve mitochondrial dysfunction, but no prior randomized controlled trials have been conducted. MATERIAL/METHODS: Thirty subjects diagnosed with an ASD were randomly assigned to...
Autores principales: | Geier, David A., Kern, Janet K., Davis, Georgia, King, Paul G., Adams, James B., Young, John L., Geier, Mark R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539542/ https://www.ncbi.nlm.nih.gov/pubmed/21629200 http://dx.doi.org/10.12659/MSM.881792 |
Ejemplares similares
-
Evidence of neurodegeneration in autism spectrum disorder
por: Kern, Janet K, et al.
Publicado: (2013) -
Evaluation of regression in autism spectrum disorder based on parental reports
por: Kern, Janet K, et al.
Publicado: (2014) -
A clinical trial of glutathione supplementation in autism spectrum disorders
por: Kern, Janet K., et al.
Publicado: (2011) -
Hair Toxic Metal Concentrations and Autism Spectrum Disorder Severity in Young Children
por: Geier, David A., et al.
Publicado: (2012) -
Examining genotypic variation in autism spectrum disorder and its relationship to parental age and phenotype
por: Geier, David A, et al.
Publicado: (2016)